Mursla, a liquid biopsy company, is delighted to announce that it has been granted patent GB 2583550B for its novel nanoelectronics-based sensitive detection method for exosomes. This unique technology harnesses the promising diagnostic power of exosomes and demonstrates its potential application for the detection of many diseases, including cancer.
Novel tech platform to trace tumours early in the blood via cancer-specific exosomes.
ideaSpace The Hauser Forum 3 Charles Babbage Road Cambridge
Post Code: CB3 0GT
Country: United Kingdom
Membership Type: Professional Individual and Corporate <5